Vagus Nerve Stimulation + Rehabilitation for Spinal Cord Injury
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether vagus nerve stimulation (VNS) can be safely and effectively combined with rehabilitation for people with spinal cord injuries. The trial includes two groups: one receives VNS during therapy sessions, while the other receives a sham (inactive) version. It targets individuals who have experienced a traumatic spinal cord injury in the neck area for over a year and can still move their upper limbs slightly, such as pinching with their fingers. The goal is to determine if VNS can improve recovery when added to regular rehabilitation exercises. As an unphased trial, this study offers participants the chance to contribute to groundbreaking research that could enhance rehabilitation outcomes for spinal cord injuries.
Will I have to stop taking my current medications?
The trial does not specify if you must stop taking your current medications, but it excludes those on medication that may interfere with the study. It's best to discuss your specific medications with the trial team.
What prior data suggests that vagus nerve stimulation is safe for spinal cord injury rehabilitation?
Research shows that vagus nerve stimulation (VNS) is generally safe for people. Studies have found that combining VNS with rehabilitation is safe for those with spinal cord injuries. One study examined the safety and feasibility of combining VNS with rehabilitation therapy and found it to be both safe and feasible. Another study assessed the safety of VNS using a device called the ReStore system and found it well-tolerated.
While VNS is usually safe, some participants in these studies experienced mild side effects, such as hoarseness, coughing, or a slight tingling sensation. Overall, the evidence suggests that VNS is a safe option for those considering participation in a clinical trial for spinal cord injury rehabilitation.12345Why are researchers excited about this trial's treatments?
Researchers are excited about this trial because it explores the potential of Vagus Nerve Stimulation (VNS) paired with rehabilitation for spinal cord injury recovery. Unlike traditional treatments that focus solely on physical therapy, this approach combines targeted rehabilitation exercises with electrical stimulation of the vagus nerve, aiming to enhance neuroplasticity and improve motor function. This unique method could offer a more effective recovery process, potentially accelerating progress and improving outcomes for patients with spinal cord injuries. By integrating VNS, the trial seeks to unlock new pathways for healing that current standard care options, which typically rely on physical therapy alone, do not address.
What evidence suggests that pairing vagus nerve stimulation with rehabilitation could be effective for spinal cord injury?
Research has shown that combining vagus nerve stimulation (VNS) with rehabilitation can improve movement. In this trial, participants in the treatment group will receive active VNS paired with rehabilitation therapy, which previous studies have shown leads to significant improvements in arm and hand movement for people with spinal cord injuries. Meanwhile, the control group will receive sham VNS with rehabilitation therapy. Studies on stroke patients have also found that VNS with rehab aids in movement recovery, suggesting that VNS might help people regain movement after nerve-related injuries. The treatment stimulates the vagus nerve, enhancing the brain's ability to heal and reorganize itself. This makes VNS a promising option for improving recovery after spinal cord injuries.12467
Who Is on the Research Team?
Radha Korupolu, MD
Principal Investigator
The University of Texas Health Science Center, Houston
Are You a Good Fit for This Trial?
This trial is for individuals at least 12 months post-traumatic cervical spinal cord injury (C8 and above), with some upper limb movement, like pinching. They must meet surgical criteria for VNS implantation. Excluded are those with non-traumatic SCI, vocal cord issues, significant brain injuries, prior vagus nerve damage, certain medications affecting neurotransmitters, other complicating conditions or surgeries, medical or mental instability, or pregnancy.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 18 goal-directed upper extremity rehabilitation therapy sessions with paired or sham VNS over six weeks
Home Exercise Program
Participants engage in a daily, 30-minute home therapy program
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Active VNS
- Arm rehabilitation
- Sham VNS
Active VNS is already approved in United States, European Union, Canada for the following indications:
- Epilepsy
- Depression
- Obesity
- Epilepsy
- Depression
- Epilepsy
- Depression
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas Health Science Center, Houston
Lead Sponsor
MicroTransponder Inc.
Industry Sponsor